Beirne Wealth Consulting Services, LLC Age X Therapeutics, Inc. Transaction History

Beirne Wealth Consulting Services, LLC

  • $285 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$0.79 - $1.52 $4,740 - $9,120
-6,000 Reduced 25.0%
18,000 $15,000
Q2 2020

Jul 31, 2020
BUY
$0.68 - $1.13 $8,160 - $13,559
12,000 Added 100.0%
24,000 $23,000
Q2 2019

Jul 25, 2019
BUY
$2.58 - $4.92 $30,960 - $59,040
12,000 New
12,000 $44,000

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0
View Full List

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Beirne Wealth Consulting Services, LLC Portfolio

Follow Beirne Wealth Consulting Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email